Prescription of drugs by artificial intelligence or machine learning technologies

Section 503(b) of Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) is amended by adding at the end the following: (6) In this subsection, the term practitioner licensed by law to administer such drug includes artificial intelligence and machine learning technology that are— (A) authorized pursuant to a statute of the State involved to prescribe the drug involved; and (B) approved, cleared, or authorized under section 510(k), 513, 515, or 564..